You have 9 free searches left this month | for more free features.

mrg002

Showing 1 - 10 of 10

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Advanced or Metastatic Urothelium Cancer Trial in Beijing (MRG002, Docetaxel Injection, Paclitaxel Injection)

Not yet recruiting
  • Advanced or Metastatic Urothelium Cancer
  • MRG002
  • +4 more
  • Beijing, Beijing, China
    Cancer Hospital Chinese Academy of Medical Sciences
Feb 22, 2023

Breast Cancer With Liver Metastases Trial in Beijing, Guangzhou (MRG002)

Recruiting
  • Breast Cancer With Liver Metastases
  • MRG002
  • Beijing, Beijing, China
  • +1 more
May 6, 2022

Advanced Solid Tumor Trial in Shanghai (MRG002)

Recruiting
  • Advanced Solid Tumor
  • MRG002
  • Shanghai, Shanghai, China
    Shanghai Oriental Hospital
Dec 2, 2021

Locally Advanced Gastric Cancer, Metastatic HER2 Positive Gastroesophageal Junction Cancer Trial in Beijing, Changsha, Shanghai

Recruiting
  • Locally Advanced Gastric Cancer
  • Metastatic HER2 Positive Gastroesophageal Junction Cancer
  • MRG002
  • Beijing, Beijing, China
  • +2 more
Feb 21, 2022

Advanced Solid Tumors, Advanced or Metastatic Gastric Cancer, Advanced or Metastatic Gastroesophageal Junction Cancer Trial in

Recruiting
  • Advanced Solid Tumors
  • +2 more
  • MRG002
  • Orange, California
  • +5 more
May 4, 2022

Non-small- Cell Lung Cancer (NSCLC) Trial in Shanghai (MRG002)

Not yet recruiting
  • Non-small- Cell Lung Cancer (NSCLC)
  • MRG002
  • Shanghai, Shanghai, China
    Shanghai Chest Hospital
Nov 19, 2021

Advanced or Metastatic Biliary Tract Cancer Trial in China (MRG002)

Recruiting
  • Advanced or Metastatic Biliary Tract Cancer
  • MRG002
  • Bengbu, Anhui, China
  • +6 more
Dec 8, 2021

Advanced or Metastatic Breast Cancer Trial in Beijing, Shijiazhuang (MRG002)

Recruiting
  • Advanced or Metastatic Breast Cancer
  • MRG002
  • Beijing, Beijing, China
  • +1 more
Jun 28, 2021

Advanced Breast Cancer, Metastatic Breast Cancer Trial in China (MRG002)

Recruiting
  • Advanced Breast Cancer
  • Metastatic Breast Cancer
  • MRG002
  • Hefei, Anhui, China
  • +18 more
Nov 29, 2021

Locally Advanced Urothelial Cancer, Metastatic Urothelial Carcinoma Trial in China (MRG002)

Recruiting
  • Locally Advanced Urothelial Cancer
  • Metastatic Urothelial Carcinoma
  • MRG002
  • Hefei, Anhui, China
  • +35 more
Dec 13, 2021